Table 3:
Characteristics | Q1 | Q2 | Q3 | Q4 | ||||
---|---|---|---|---|---|---|---|---|
HR (95% CI) | P* | HR (95% CI) | P* | HR (95% CI) | P* | |||
Central arterial stiffness | ||||||||
cfPWV | Model 1 | 1.01 (0.65, 1.57) | 0.96 | ref | 1.76 (1.19, 2.62) | 0.01 | 1.55 (1.04, 2.32) | 0.03 |
Model 2 | 1.11 (0.71, 1.73) | 0.65 | ref | 1.60 (1.08, 2.39) | 0.02 | 1.24 (0.82, 1.87) | 0.30 | |
Model 3 | 1.13 (0.72, 1.76) | 0.59 | ref | 1.55 (1.04, 2.32) | 0.03 | 1.13 (0.74, 1.72) | 0.57 | |
Model 4 | 1.07 (0.69, 1.68) | 0.75 | ref | 1.44 (0.96, 2.15) | 0.07 | 0.99 (0.65, 1.51) | 0.96 | |
hfPWV | Model 1 | 1.08 (0.71, 1.66) | 0.71 | ref | 1.39 (0.92, 2.09) | 0.11 | 1.71 (1.15, 2.53) | 0.01 |
Model 2 | 1.21 (0.79, 1.86) | 0.39 | ref | 1.26 (0.84, 1.90) | 0.27 | 1.38 (0.92, 2.06) | 0.12 | |
Model 3 | 1.28 (0.83, 1.96) | 0.27 | ref | 1.21 (0.80, 1.82) | 0.37 | 1.21 (0.80, 1.83) | 0.37 | |
Model 4 | 1.25 (0.81, 1.93) | 0.31 | ref | 1.19 (0.79, 1.80) | 0.40 | 1.02 (0.67, 1.55) | 0.94 | |
Derived CFVI | Model 1 | 1.24 (0.80, 1.93) | 0.33 | ref | 1.51 (0.99, 2.30) | 0.06 | 2.03 (1.36, 3.03) | 0.001 |
Model 2 | 1.31 (0.85, 2.04) | 0.22 | ref | 1.30 (0.85, 2.00) | 0.22 | 1.56 (1.03, 2.36) | 0.04 | |
Model 3 | 1.42 (0.92, 2.21) | 0.12 | ref | 1.26 (0.82, 1.93) | 0.29 | 1.40 (0.92, 2.14) | 0.11 | |
Model 4 | 1.40 (0.90, 2.18) | 0.13 | ref | 1.24 (0.81, 1.90) | 0.32 | 1.23 (0.81, 1.89) | 0.33 | |
Composite arterial stiffness | ||||||||
baPWV | Model 1 | 0.92 (0.62, 1.37) | 0.69 | ref | 1.08 (0.73, 1.59) | 0.69 | 1.65 (1.16, 2.35) | 0.01 |
Model 2 | 1.06 (0.71, 1.59) | 0.76 | ref | 0.99 (0.67, 1.45) | 0.95 | 1.33 (0.93, 1.90) | 0.12 | |
Model 3 | 1.06 (0.70, 1.59) | 0.78 | ref | 0.98 (0.66, 1.45) | 0.91 | 1.27 (0.87, 1.85) | 0.21 | |
Model 4 | 1.02 (0.68, 1.54) | 0.92 | ref | 0.99 (0.67, 1.46) | 0.95 | 1.28 (0.88, 1.86) | 0.21 | |
haPWV | Model 1 | 1.06 (0.70, 1.60) | 0.79 | ref | 1.02 (0.67, 1.55) | 0.93 | 1.59 (1.08, 2.34) | 0.02 |
Model 2 | 1.18 (0.78, 1.79) | 0.44 | ref | 0.94 (0.61, 1.43) | 0.76 | 1.25 (0.85, 1.85) | 0.26 | |
Model 3 | 1.26 (0.83, 1.92) | 0.29 | ref | 0.88 (0.58, 1.35) | 0.57 | 1.07 (0.71, 1.61) | 0.74 | |
Model 4 | 1.22 (0.80, 1.86) | 0.36 | ref | 0.87 (0.57, 1.33) | 0.51 | 1.06 (0.70, 1.60) | 0.79 | |
Derived CAVI | Model 1 | 1.30 (0.84, 2.03) | 0.24 | ref | 1.63 (1.07, 2.49) | 0.02 | 1.98 (1.32, 2.99) | 0.001 |
Model 2 | 1.37 (0.88, 2.14) | 0.16 | ref | 1.39 (0.91, 2.13) | 0.13 | 1.42 (0.93, 2.16) | 0.11 | |
Model 3 | 1.54 (0.99, 2.41) | 0.06 | ref | 1.37 (0.89, 2.10) | 0.15 | 1.24 (0.81, 1.91) | 0.32 | |
Model 4 | 1.45 (0.93, 2.27) | 0.11 | ref | 1.34 (0.87, 2.06) | 0.18 | 1.25 (0.81, 1.92) | 0.32 |
Model 1: Crude
Model 2: Age, sex, race
Model 3: Model 2 + education, current smoking, body mass index, history of diabetes, mean arterial pressure, antihypertensive medication, total cholesterol, high-density lipoprotein
Model 4: Model 3 + ankle brachial index, estimated glomerular filtration rate, albumin-creatinine ratio
HR=hazard ratio; Q1, Q2, Q3, Q4=quartile 1, quartile 2, quartile 3, quartile 4
P-values test quartile-specific estimates vs. the referent (quartile 2)